| |
Objective of therapy | Possible influence | References | | Direct tissue remodelling (including 2D, 3D biomaterials) | “Type-like” cell effects | Paracrine mechanisms | |
| | Liver | | + | + | Campard et al., 2008 [35];
Tsai et al., 2009 [36];
Anzalone et al., 2010 [37];
Shi et al., 2012 [38];
Wang et al., 2013 [39] |
| | Heart and cardiovascular system | + | | + | Kadner et al., 2002 [40];
Corrao et al., 2013 [41];
López et al., 2013 [42];
Nascimento et al., 2014 [43] |
| | Kidneys and excretory system | | | + | Du et al., 2012 [44];
Song et al., 2014 [45] |
| | Central and peripheral nervous systems | + | + | + | Weiss et al., 2003 [46];
Fu et al., 2004 [47];
Fu et al., 2006 [48];
Weiss et al., 2006 [49];
Joyce et al., 2010 [50];
Matsuse et al., 2010 [51];
Carvalho et al., 2011 [52];
Dongmei et al., 2011 [53]
Zhang et al., 2011 [54];
Dalous et al., 2012 [55];
Hsieh et al., 2013 [56];
Taran et al., 2014 [57] |
| | Cartilage | + | | + | Wang et al., 2009 [58];
Arufe et al., 2011 [59];
lo Iacono et al., 2011 [60] |
| | Metabolic regulation, immune system, and autoimmune diseases | | | + | Tyndall and Uccelli, 2009 [61];
Mazzini et al., 2010 [62];
Uccelli and Prockop, 2010 [63];
Liu et al., 2014 [64] |
| | Skin | + | | + | Shohara et al., 2012 [65];
Arno et al., 2014 [66] |
| | Lungs and respiratory system | | | + | Lee et al., 2011 [67];
Weiss, 2014 [68] |
|
|
